China to manage monkeypox as disease on par with COVID-19
Send a link to a friend
[September 15, 2023]
BEIJING (Reuters) -China plans to manage monkeypox in the same
way it handles infectious diseases such as COVID-19 starting from Sept.
20, health authorities said on Friday, after detecting around 500 cases
of the viral infection last month.
Monkeypox will be managed under Category B protocols, the National
Health Commission (NHC) said in a statement.
Under this category, China could take emergency measures such as
restricting gatherings, suspending work and school or sealing off areas
when there is an outbreak of a disease.
Category B infectious diseases currently include COVID-19, AIDS and SARS.
"Over 20 provinces have reported monkeypox cases in China since the
first imported case in September 2022 and the beginning of locally
transmitted cases in June 2023, triggering continued outbreaks and
'hidden' transmissions," the NHC said.
China puts infectious diseases into three classes, with the top level
Category A giving authorities the power to quarantine patients and their
close contacts.
China downgraded the management of COVID-19 to Category B from Category
A at the end of 2022 after almost three years of strict restrictions
that included locking down entire cities.
[to top of second column]
|
Mock-up vials labeled "Monkeypox vaccine" and medical syringe are
seen in this illustration taken, May 25, 2022. REUTERS/Dado Ruvic/Illustration/File
Photo
In August, China reported 501 new
monkeypox infections, with no severe cases or deaths, the Chinese
Center For Disease Control and Prevention said on Sept.8.
First identified in monkeys, the virus is transmitted chiefly
through close contact with an infected person.
In May, the World Health Organization declared that monkeypox was no
longer a global public health emergency.
(Reporting by Ethan Wang and Ryan Woo; Editing by Jacqueline Wong
and Miral Fahmy)
[© 2023 Thomson Reuters. All rights
reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |